PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 50 filers reported holding PANACEA ACQUISITION CORP II in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,228,944 | +1.7% | 707,333 | 0.0% | 0.16% | +30.6% |
| Q4 2022 | $7,108,697 | -12.8% | 707,333 | -15.0% | 0.12% | +21.6% |
| Q3 2022 | $8,155,000 | +0.4% | 832,156 | 0.0% | 0.10% | +18.6% |
| Q2 2022 | $8,122,000 | +0.1% | 832,156 | +0.0% | 0.09% | +36.5% |
| Q1 2022 | $8,114,000 | +4.8% | 832,155 | +4.3% | 0.06% | -4.5% |
| Q4 2021 | $7,742,000 | -0.7% | 798,200 | 0.0% | 0.07% | +3.1% |
| Q3 2021 | $7,799,000 | -2.4% | 798,200 | 0.0% | 0.06% | +10.3% |
| Q2 2021 | $7,994,000 | – | 798,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIT CAPITAL PARTNERS PLC | 900,000 | $8,766,000 | 3.64% |
| MYDA Advisors LLC | 580,000 | $5,655,000 | 2.23% |
| 683 Capital Management, LLC | 1,480,000 | $14,430,000 | 0.77% |
| Sage Rock Capital Management LP | 382,500 | $3,729,000 | 0.67% |
| Bain Capital Life Sciences Investors, LLC | 500,000 | $4,875,000 | 0.47% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,638,750 | $16,027,000 | 0.37% |
| Boxer Capital, LLC | 500,000 | $4,875,000 | 0.25% |
| MAVERICK CAPITAL LTD | 1,385,250 | $13,506,000 | 0.24% |
| Governors Lane LP | 250,000 | $2,441,000 | 0.18% |
| Greenlight Capital | 275,000 | $2,681,000 | 0.17% |